Treatment of uveitis by oral administration of retinal antigens: Results of a phase I/II randomized masked trial

American Journal of Ophthalmology

Volumn 123, Issue 5, 1997, Pages 583-592

  Nussenblatt, R B ^a   Gery, I ^a   Weiner, H L ^a   Ferris, F L ^a   Shiloach, J ^a   Remaley, N ^a   Perry, C ^a   Caspi, R R ^a   Hafler, D A ^a   Foster, C S ^a   Whitcup, S M ^a  

^a NATIONAL EYE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIUM SULFATE; CORTICOSTEROID; CYCLOSPORIN; CYTOTOXIC AGENT; IMMUNOSUPPRESSIVE AGENT; INTERPHOTORECEPTOR RETINOID BINDING PROTEIN; PLACEBO; PREDNISONE; RETINA ANTIGEN; RETINA S ANTIGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG APPROVAL; DRUG CAPSULE; DRUG EFFICACY; DRUG MIXTURE; DRUG SAFETY; DRUG TOLERANCE; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; ORAL DRUG ADMINISTRATION; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME; UVEITIS; VISUAL ACUITY;

EID: 0030946927     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(14)71070-0     Document Type: Article

References (35)

1. National Institutes of Health. Interim report of the National Advisory Eye Council support for visual research. Washington, DC: US Department of Health, Education, and Welfare, 1976
2. Nussenblatt RB Whitcup SM Palestine AG Uveitis: fundamentals and clinical practice 1996 Mosby St Louis 97 134
3. Nussenblatt RB Experimental autoimmune uveitis: mechanisms of disease and clinical therapeutic indications [Proctor lecture] Invest Ophthalmol Vis Sci 32 1991 3131 3141
4. Wells H Studies on the chemistry of anaphylaxis, III: experiments with isolated proteins, especially those of hen's egg J Infect Dis 9 1911 147 171
5. Chase MW Inhibition of experimental drug allergy by prior feeding of the sensitizing agent Proc Soc Exp Biol Med 61 1946 257 259
6. Lider O Santos LMB Lee CSY Higgins PJ Weiner HL Suppression of experimental allergic encephalomyelitis by oral administration of myelin basic protein, II: suppression of disease and in vitro immune responses are mediated by antigen-specific CD8+ T lymphocytes J Immunol 142 1989 748 752
7. Whitacre CC Gienapp IE Orosz CG Bitar D Oral tolerance in experimental autoimmune encephalomyelitis, III: evidence for clonal anergy J Immunol 147 1991 2155 2163
8. Miller A Al-Sabbagh A Santos LMB Epitopes of myelin basic protein that trigger TGF-β release after oral tolerance are distinct from encephalitogenic epitopes and mediate epitope-driven bystander suppression J Immunol 151 1993 7307 7315
9. Miller A Lider O Al-Sabbagh A Weiner HL Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein, V: hierarchy of suppression by myelin basic protein from different species J Neuroimmunol 39 1992 243 250
10. Nagler-Anderson C Bober LA Robinson ME Siskind GW Thorbeke FJ Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen Proc Natl Acad Sci USA 83 1986 7443 7446
11. Thompson HSG Staines NA Gastric administration of type II collagen delays the onset and severity of collagen-induced arthritis in rats Clin Exp Immunol 64 1986 581 586
12. Zhang JZ Lee CSY Lider O Weiner HL Suppression of adjuvant arthritis in Lewis rats by oral administration of type II collagen J Immunol 145 1990 2489 2493
13. Zhang JA Davidson L Eisenbarth G Weiner HL Suppression of diabetes in NOD mice by oral administration of porcine insulin Proc Natl Acad Sci USA 88 1991 10252 10256
14. Bergerot J Fabien N Maguer V Thivolet C Oral administration of human insulin to NOD mice generates CD4+ T cells that suppress adoptive transfer of diabetes J Autoimmun 7 1994 655 663
15. Nussenblatt RB Caspi RR Mahdi R Inhibition of S-antigen induced experimental autoimmune uveoretinitis by oral induction of tolerance with S-antigen J Immunol 144 1990 1689 1695
16. Gregerson DS Obritsch WF Donoso LA Oral tolerance in experimental autoimmune uveoretinitis: distinct mechanisms of resistance are induced by low versus high-dose feeding protocols J Immunol 151 1993 5751 5761
17. Rizzo LV Miller-Rivero NE Chan CC Wiggert B Nussenblatt RB Caspi RR Interleukin-2 treatment potentiates induction of oral tolerance in a murine model of autoimmunity J Clin Invest 94 1994 1668 1672
18. Nussenblatt RB Whitcup S de Smet MD Intraocular inflammatory disease (uveitis) and the use of oral tolerance: a status report 778 1996 Ann N Y Acad Sci New York 325 337
19. Nussenblatt RB, de Smet MD, Weiner HL, Gery I. The treatment of ocular complications of Behçet's disease with oral tolerization. Proceedings of the Sixth International Conference on Behçet's Disease, 1993. Amsterdam: Excerpta Medica, 1993
20. Nussenblatt RB Palestine AG Chan CC Standardization of vitreal inflammatory activity in intermediate and posterior uveitis Ophthalmology 92 1985 467 471
21. Nussenblatt RB Gery I Ballantine EJ Cellular immune responsiveness of uveitis patients to retinal S-antigen Am J Ophthalmol 89 1980 173 179
22. Ferris FL III Kassoff A Bresnick GH Bailey I New visual acuity charts for clinical research Am J Ophthalmol 94 1982 91 96
23. Cox DR Regression models and life-tables J R Stat Soc 34 1972 187 220
24. Kalbfleisch JD Prentice RL The statistical analysis of failure time data 1980 Wiley New York
25. Bloch-Michel E Nussenblatt RB International uveitis study group recommendations for the evaluation of intraocular inflammatory disease Am J Ophthalmol 103 1987 234 235
26. Weiner HL Mackin GA Matsui M Orav EJ Khoury SJ Dawson DM Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis Science 259 1993 1321 1324
27. Trentham DE Dynesius-Trentham RA Orav EJ Effects of oral administration of type II collagen on rheumatoid arthritis Science 261 1993 1727 1730
28. Brod SA Al-Sabbagh A Sobel RA Hafler DA Weiner HL Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin antigens, IV: suppression of chronic relapsing disease in the Lewis rat and strain 13 guinea pig Ann Neurol 29 1991 615 622
29. Wang Z-Y He B Qiao J Link H Suppression of experimental autoimmune myasthenia gravis and experimental allergic encephalomyelitis by oral administration of acetylcholine receptor and myelin basic protein: double tolerance J Neuroimmunol 63 1995 79 86
30. Chen Y Inobe J-I Marks R Gonnella P Kuchroo VK Weiner HL Peripheral deletion of antigen-reactive T cells in oral tolerance Nature 376 1995 177 180
31. Chen Y Kuchroo VK Inobe J-I Hafler DA Weiner HL Regulatory T-cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis Science 265 1994 1237 1240
32. Chen Y Inobe J-I Kuchroo VK Baron JL Janeway CA Weiner HL Oral tolerance in myelin basic protein T-cell receptor transgenic mice: suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells Proc Natl Acad Sci USA 93 1996 388 391
33. Fukaura H Kent SC Pietrusewicz MJ Khoury SJ Weiner HL Hafler DA Induction of circulating myelin basic protein and proteolipid protein specific TGF-β1-secreting T cells by oral administration of myelin in multiple sclerosis patients J Clin Invest 98 1996 70 77
34. Suh EDW Vistica B Chan CC Gery I Nussenblatt RB Splenectomy abrogates the induction of oral tolerance in experimental autoimmune uveoretinitis Curr Eye Res 12 1993 833 839
35. Hohol MJ Khoury SJ Cook SL Orav J Hafler DA Weiner HL Three-year open protocol continuation study of oral tolerization with myelin antigens in multiple sclerosis and design of a phase III pivotal trial Weiner HL Mayer LF Oral tolerance: mechanisms and applications 778 1996 Ann N Y Acad Sci New York 243 250